Comparison of Buffered and Unbuffered Acetylsalicylic Acid
- 30 January 1958
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 258 (5) , 213-219
- https://doi.org/10.1056/nejm195801302580503
Abstract
FEW drugs have such a wide clinical use and acceptance as acetylsalicylic acid. Gerhardt1 synthesized this substance in 1853, but it remained for Hoffman, a chemist at Bayer's chemical works at Elberfeld, Germany, to rediscover the compound. The inadequacy of prolonged use of salicylic acid for the treatment of his father's rheumatoid arthritis prompted Hoffman to try acetylsalicylic acid. Because of its success he influenced Dreser, the director of Bayer's pharmacologic research, to initiate pharmacologic and clinical studies. In 1899 Dreser2 presented the first pharmacologic data, and Wohlgemut3 the first clinical report. Thus began a literature that is now too . . .Keywords
This publication has 6 references indexed in Scilit:
- BUFFERIN IN THE MANAGEMENT OF RHEUMATOID ARTHRITISJAMA, 1955
- CLINICAL ASPECTS OF THE EVALUATION OF ANALGESIC AGENTSJAMA, 1954
- THE PRESENCE OF ASPIRIN IN HUMAN PLASMA AFTER ORAL ADMINISTRATION1954
- Effect of Buffering Agents on Absorption of Acetysalicylic AcidJournal of the American Pharmaceutical Association (Scientific ed.), 1950
- THE INCIDENCE OF ASPIRIN HYPERSENSITIVITYThe Lancet Healthy Longevity, 1940
- Pharmakologisches über Aspirin (Acetylsalicylsäure)Pflügers Archiv - European Journal of Physiology, 1899